Weighted Average Number of Shares Outstanding, Basic of Propanc Biopharma, Inc. from Q1 2021 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Propanc Biopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from Q1 2021 to Q3 2025.
  • Propanc Biopharma, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 12.3M shares, a 125106% increase year-over-year.
  • Propanc Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 3.97M shares.
  • Propanc Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 1.42K shares.
  • Propanc Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 1.74M shares, a 2449% increase from 2022.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Propanc Biopharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 12.3M +12.3M +125106% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 3.97M 01 Apr 2025 30 Jun 2025 10-K 29 Sep 2025
Q1 2025 4.33M +4.33M 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q4 2024 13.3K +13K 01 Oct 2024 31 Dec 2024 10-Q 14 Feb 2025
Q3 2024 9.85K -11M -99.9% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025
Q1 2024 994* -1.92M 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q4 2023 397* -960K 01 Oct 2023 31 Dec 2023 10-Q 14 Feb 2025
Q3 2023 11M +10.5M +2221% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 1.74M +1.67M +2449% 01 Apr 2023 30 Jun 2023 10-K 30 Sep 2024
Q1 2023 1.92M -64.4M -97.1% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 960K -48.4M -98.1% 01 Oct 2022 31 Dec 2022 10-Q 20 Feb 2024
Q3 2022 474K -26.7M -98.3% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 68.2K 01 Apr 2022 30 Jun 2022 10-K 28 Sep 2023
Q1 2022 66.4M +62.9M +1822% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 49.4M 01 Oct 2021 31 Dec 2021 10-Q 10 Feb 2023
Q3 2021 27.1M 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q1 2021 3.45M 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022

Propanc Biopharma, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 3.97M +3.97M 01 Jul 2024 30 Jun 2025 10-K 29 Sep 2025
2024 1.42K* -1.74M 01 Jul 2023 30 Jun 2024 10-K 29 Sep 2025
2023 1.74M +1.67M +2449% 01 Jul 2022 30 Jun 2023 10-K 30 Sep 2024
2022 68.2K -2.96M -97.8% 01 Jul 2021 30 Jun 2022 10-K 28 Sep 2023
2021 3.03M 01 Jul 2020 30 Jun 2021 10-K 28 Sep 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.